CME – Optogenetics for Inherited Retinal Diseases

In recent years, clinical research has dramatically advanced our understanding of inherited retinal degenerations (IRDs). Dozens of emerging therapies are currently the subject of clinical investigation and may soon enter the treatment landscape for patients suffering from IRD related sight loss. These trials offer the hope of restored visual function for IRD patients and their families.

Most eye care professionals outside of academic research centers aren’t aware of the advancements in gene therapy (i.e., clinical trials) that might benefit patients with inherited retinal diseases. Optogenetics – the topic of this course – is a novel therapy that combines genetic engineering and neurobiology to restore visual function for patients with advanced vision loss, regardless of the gene causing their vision loss.

As a result of participation in this course, participants will be able to:

• Define basic optogenetics concepts and approaches
• Describe the opportunities and limitations of optogenetic therapies
• Identify patients who might be candidates for optogenetic therapies

To learn more about the course, visit the main Continuing Medical Education page.